MedTrace Logo

Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor

NCT07570485 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-06-12

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.

The main question it aims to answer is:

What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?

Additional questions include:

* What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program?
* What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)?
* What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?

Participants will:

* Undergo a 3-month supervised APA program (with possible continuation beyond this period).
* Use connected watches to monitor physical activity (if they accept the general conditions of use).
* Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months.
* Be followed for a total of 4 months after inclusion.

Conditions

  • Brain Tumor Adult

Interventions

OTHER

adapted physical activity

Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.

Sponsors & Collaborators

  • University of Rennes 2

    collaborator OTHER

  • Center Eugene Marquis

    lead OTHER

Principal Investigators

  • Elodie VAULEON, Dr · Centre de lutte contre le cancer Eugène Marquis

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2028-06-01
Completion
2028-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07570485 on ClinicalTrials.gov